NSG BioLabs, Singapore’s leading provider of biotech co-working laboratory and office spaces, has joined forces with the Life Science business of Merck Singapore to enhance the research and development capabilities of biotech startups. This strategic partnership will provide NSG BioLabs’ tenants with access to valuable resources and expertise, creating opportunities for funding, partnerships, production, and commercialization of their innovations.
Chua Keng Hock, Managing Director of Merck Singapore and Senior Vice President of Process Solutions for APAC, emphasized the significance of this collaboration, stating, “Our partnership with NSG BioLabs reflects Merck Singapore’s dedication to fostering the growth and development of the biotech community both in Singapore and across the Asia Pacific region. Merck offers one of the most comprehensive portfolios in the industry, supporting every stage from research discovery to pharmaceutical development, testing, and the manufacturing of traditional and novel modalities. Additionally, our M Lab Collaboration Center in Singapore provides off-site trial support and training on large-scale equipment in a GMP-like environment.”
Since its inception in 2019, NSG BioLabs has been a pivotal force in helping innovators develop impactful solutions in sectors such as health, biomedical, agrifood, and industrial biotechnology. The company’s tenants work on cutting-edge projects in areas like precision medicine, nucleic acids, AI-enabled drug discovery, and synthetic biology. As the largest provider of co-working biotech laboratory and office space in Singapore, NSG BioLabs boasts an extensive network of local and international partners, suppliers, and industry experts. This robust ecosystem has supported over 40 resident companies, including several multi-billion-dollar multinationals and numerous promising startups that have reached significant milestones. Collectively, these startup residents have successfully raised nearly $400 million in funding and have created hundreds of jobs, further contributing to the vibrant biotech landscape in Singapore.
